Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting, 42823 [2017-19232]
Download as PDF
<![CDATA[
42823
Federal Register / Vol. 82, No. 175 / Tuesday, September 12, 2017 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Form name
Total
responses
Average burden
per response
(in hours)
Total burden
hours
(rounded up)
Missing Report Form .........................................................
Subject Statement and Dispute .........................................
Request for Dispute Resolution .........................................
Electronic Transfer of Funds (EFT) Authorization .............
Authorized Agent Designation ...........................................
Account Discrepancy .........................................................
New Administrator Request ...............................................
Query Credit Purchase ......................................................
Educational Request ..........................................................
Account Balance Transfer .................................................
29
3,547
99
654
213
10
3,016
789
10
10
1
1
1
1
1
1
1
1
1
1
29
3,547
99
654
213
10
3,016
789
10
10
.08
.75
8
.08
.25
.25
.08
.08
.08
.08
3
2,661
792
53
54
3
242
64
1
1
Total ............................................................................
6,059,761
........................
6,059,761
..........................
326,120
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2017–19252 Filed 9–11–17; 8:45 am]
BILLING CODE 4165–15–P
Dated: September 6, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2017–19232 Filed 9–11–17; 8:45 am]
pmangrum on DSK3GDR082PROD with NOTICES1
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Developmental Biology
Subcommittee.
VerDate Sep<11>2014
15:19 Sep 11, 2017
Jkt 241001
Date: October 2, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda Downtown,
7335 Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS, 6710
B Rockledge Drive, Bethesda, Maryland
20892, 301–435–6878, wedeenc@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
Government owned
intellectual property covering imaging
agents with improved renal clearance
available for licensing and
commercialization.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by emailing the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Transfer and Development Office of
Technology Transfer, 31 Center Drive,
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
SUPPLEMENTARY INFORMATION: The
inventions listed below are owned by an
agency of the U.S. Government and are
available for licensing in the U.S. in
accordance with 35 U.S.C. 209 and 37
CFR part 404 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing. A description of the
technology available for licensing
follows.
Evans Blue Dye Derivatives for Serum
Albumin Labeling
Description of Technology: The
invention is an imaging agent and
method of its use for imaging blood
pools and the lymphatic system. The
imaging agent binds with high affinity
to serum albumin, the most abundant
serum protein, and can be tagged with
several isotopes making it suitable for
magnetic resonance imaging or positron
emission tomographic imaging. To date,
only very few blood-pool tracers have
been introduced for positron emission
tomography. The existing ones have
short half-lives (20.4 min for 11C and
2.05 min for 15O) and thus can only be
used in centers with an in-house
cyclotron. Compared with these
radiometals, 18F has the advantages of
being a pure position emitter with ideal
half-life. It is the dominant radioisotope
used for PET imaging for both clinical
applications and preclinical
investigations. Evans blue dye has been
an important tool in many physiological
and clinical investigations because of its
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 82, Number 175 (Tuesday, September 12, 2017)]
[Notices]
[Page 42823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19232]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and
Human Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Developmental Biology
Subcommittee.
Date: October 2, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda Downtown, 7335 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, DHHS,
6710 B Rockledge Drive, Bethesda, Maryland 20892, 301-435-6878,
wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 6, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19232 Filed 9-11-17; 8:45 am]
BILLING CODE 4140-01-P
